Event

9

February 2018

The Life Sciences Industry of Tomorrow: Healthy Canadians, Healthy Future

11:30am-1:30pm | Fairmont Royal York - 100 Front Street West, Toronto, Toronto

The life sciences are innovating at an unprecedented pace, is government policy keeping up or holding us back?

Whether it’s artificial intelligence or new gene therapies that can potentially cure cancer, we are at a pivotal moment in the evolution and adoption of new technologies that will fundamentally change how we live, work, and treat illness. Access to these breakthrough technologies is key to our future health and prosperity and Canadians at the cutting edge of many of these new discoveries expect no less. But as Pamela Fralick, President of Innovative Medicines Canada explains, proposed policy changes to Canada’s patented drug pricing regime will have profound implications for Canadian healthcare and life sciences for decades to come.

- Lunch will be served -

Member price:
Individual seat: $89 +HST
Table (seats 10): $800 +HST

Regular price:
Individual seat: $110 +HST
Table (seats 10): $990 +HST

Important:
- For information about accessibility, please email dickinson@economicclub.ca
- Dietary restriction notes and meal requests must be submitted to dickinson@economicclub.ca by Friday, February 2, 2018.

*The views expressed on the Economic Club platform are not that of the Economic Club or its affiliates but of the speakers alone and the organizations they represent*

Brian Hilberdink

President
Novo Nordisk Canada Inc.

Brian Hilberdink

Mr. Brian Hilberdink has been the President of Novo Nordisk Canada Inc. since July 24, 2015. Mr. Hilberdink is an accomplished executive with 20 years of global and domestic experience developing and executing Novo Nordisk's commercial strategy. He served as Vice President of Diabetes Marketing and Market Access at Novo Nordisk Canada. Prior to this role, he served as Corporate Vice President, Global Marketing, Novo Nordisk A/S, and led the commercialization of its future insulin portfolio, from phase 2 clinical development until the first launches in Europe and Japan. He also has experience working in the U.S. where, as Director of Brand Management, he led multiple brand teams during a period of significant growth for Novo Nordisk U.S.

Dr. Jason Field

President & CEO
Life Sciences Ontario

Dr. Jason Field

Dr. Jason Field is the President and CEO of Life Sciences Ontario (LSO), the industry voice for the life sciences sector in Ontario. LSO is a member-driven organization that represents and promotes the province's vibrant and diverse life sciences sector. LSO collaborates with governments, academia, industry and other life science organizations in Ontario and across Canada to promote and encourage commercial success throughout this diverse sector. Jason obtained his PhD in Chemistry from the University of Massachusetts and his undergraduate degree from the University of Waterloo. Following graduate school, Jason returned to Ontario and worked in the pharmaceutical industry as a research scientist developing scalable manufacturing processes of active pharmaceutical ingredients. In 2007, he joined the Ministry of Economic Development and Trade (MEDT) where he led a team of senior advisors dedicated to growing Ontario's life sciences and information and communication technologies (ICT) sectors. During his time at MEDT, Jason was integral to the development of a number of strategic policy initiatives and spearheaded negotiations with several major ICT and life sciences companies that resulted in significant new investments in the province. Jason joined LSO as Executive Director in October, 2011 and was appointed as President and CEO in April, 2014.

Janet Yale

President & CEO
The Arthritis Society of Canada

Janet Yale

Janet Yale is the president and CEO of The Arthritis Society (Canada). Janet previously served as executive vice president at TELUS, and president and CEO of the Canadian Cable Television Association, along with other c-suite roles in private, public and not -for-profit organizations.

Currently Janet chairs the Arthritis Alliance of Canada, Past-Chair of the Ontario Trillium Foundation, and serves on the boards of Samara and the Ottawa Art Gallery. Janet is a recipient of the Queen Elizabeth II Diamond Jubilee Medal.

Pamela Fralick

President
Innovative Medicines Canada

Pamela Fralick

Pamela Fralick is an experienced leader who has been fostering positive change in Canada’s health sector for decades. Throughout her career, Ms. Fralick has distinguished herself in a variety of senior roles. A convener and innovator, Ms. Fralick is one of Canada’s leading, compassionate voices in the health sector. As the President of Innovative Medicines Canada, Ms. Fralick leads the industry association for Canada’s innovative pharmaceutical companies, working with its members and communities to ensure Canadians have access to the medicines they need, when they need them.

Prior to joining Innovative Medicines Canada, Ms. Fralick was President and CEO of the Canadian Cancer Society, Canada’s largest health charity, where she oversaw a three-year process of intense transformation, resulting in historic changes to the operational and governance structures of the organization.

Ms. Fralick previously served as president and CEO of the Canadian Healthcare Association (CHA) and as CEO of the Canadian Physiotherapy Association. At both Associations, Ms. Fralick led organizational initiatives designed to enhance sustainability and improve outcomes for the associations, their members and stakeholders. Ms. Fralick has also held senior positions with the Canadian Centre on Substance Abuse and Health Canada’s Alcohol and Other Drugs Unit.

True to her commitment to the health and well-being of Canadians, Ms. Fralick has served on numerous prestigious boards and collaboratives across Canada. She was Chair of the Health Action Lobby (HEAL) and Co-chair the Canadian Coalition for Public Health in the 21st Century (CCPH21). She has been active in many organizations as a senior volunteer, including the Centre for Addiction and Mental Health, the University of Ottawa Institute of Mental Health Research, Triathlon Canada and the International Triathlon Union. She is currently on the board of Outward Bound Canada (Chair) and the Canada Dance Festival (Past Chair).

Ms. Fralick has a BA in French and psychology and an MA in developmental psychology from Carleton University, as well as a Master of Public Administration (MPA) from Queen’s University. She also holds an ICD.D designation. She is trilingual – in English, French and German – and is an accomplished artist and athlete.

Wayne Critchley

Moderator
Former Executive Director, PMPRB

Wayne Critchley

Wayne Critchley is Senior Associate with Global Public Affairs' Health & Life Sciences practice, providing counsel to leading biopharmaceutical and medical device corporations and associations along with other health policy stakeholders.

Wayne has a long track record of success as a senior executive with over twenty years of experience in government departments, boards and agencies dealing primarily with issues that impact the pharmaceutical sector. He served as Executive Director of the Patented Medicine Prices Review Board from 1990 to 2005 and as a Vice President of the Canadian Agency for Drugs and Technologies in Health in 2009. Prior to 1990, Wayne occupied several senior positions in the Competition Bureau.

His private sector experience includes providing high impact strategic advice and counsel to the innovative life sciences sector as a partner in one of Canada's leading law firms and he is widely recognized as an expert in pharmaceutical pricing, reimbursement and market access. Wayne is regularly called upon to write and present on Canadian pharmaceutical issues.

Wayne serves on the Board of Directors of the Canadian Organization for Rare Disorders. He is also a member of the Board of Directors of the Canadian Club of Ottawa and was President from 2012-2013.

Our Sponsors